Monoprost

DRUG4 trials

Sponsors

Rigshospitalet, Laboratoires Thea, CHA University, Rigshospitalet, Denmark

Conditions

GlaucomaOcular HypertensionOcular hypertensionPrimary Open Angle GlaucomaPrimary open angle glaucoma

Phase 4

Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose

CompletedNCT02017327

Laboratoires TheaOcular Hypertension, Primary Open Angle Glaucoma

Start: 2013-12-31End: 2016-07-31Updated: 2020-04-02

Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost

CompletedNCT04743622

CHA UniversityGlaucoma, Ocular Hypertension

Start: 2019-04-30End: 2020-09-13Updated: 2021-02-08

Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells

RecruitingNCT04957329

Rigshospitalet, DenmarkGlaucoma, Ocular Hypertension

Start: 2021-09-01End: 2026-12-31Target: 28Updated: 2023-11-18

The GOBLET trial: A clinical trial on GOblet cell density after Benzalkonium chloride and preservative-free Latanoprost Eye drop Treatment

CompletedCTIS2024-512275-12-00

RigshospitaletOcular hypertension, Primary open angle glaucoma

End: 2025-08-04Target: 28Updated: 2024-10-29